Literature DB >> 3071185

Expression of Met-(-1) angiogenin in Escherichia coli: conversion to the authentic less than Glu-1 protein.

R Shapiro1, J W Harper, E A Fox, H W Jansen, F Hein, E Uhlmann.   

Abstract

A method for obtaining authentic human angiogenin utilizing an Escherichia coli recombinant expression system is described. A synthetic gene encoding angiogenin was placed into a vector for direct expression under the control of a modified E. coli trp promoter. The protein was produced by the bacteria in an insoluble form and purified to homogeneity by cation-exchange and reversed-phase HPLC following reduction/solubilization and reoxidation. The protein isolated was identified as Met-(-1) angiogenin by amino acid analysis and tryptic peptide mapping; the latter demonstrated that all three disulfide bonds had formed correctly. Both the enzymatic and angiogenic activities of the Met-(-1) protein were equivalent to those of native angiogenin. A Met-(-1) Leu-30 derivative of angiogenin was also isolated and found to be fully active. Conversion of Met-(-1) angiogenin to the authentic less than Glu-1 protein was achieved by treatment with Aeromonas aminopeptidase under conditions in which the new N-terminal glutamine readily cyclizes nonenzymatically. This aminopeptidase treatment may have more general applicability for removal of undesirable N-terminal methionine residues from foreign proteins expressed in bacteria.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3071185     DOI: 10.1016/0003-2697(88)90569-6

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  23 in total

1.  Dual site model for the organogenic activity of angiogenin.

Authors:  T W Hallahan; R Shapiro; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.

Authors:  A C Papageorgiou; R Shapiro; K R Acharya
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

3.  Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoter.

Authors:  Jinghao Sheng; Wenhao Yu; Xiangwei Gao; Zhengping Xu; Guo-Fu Hu
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

4.  Angiogenin inhibits nuclear translocation of apoptosis inducing factor in a Bcl-2-dependent manner.

Authors:  Shuping Li; Wenhao Yu; Guo-Fu Hu
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

5.  Modular mutagenesis of human placental ribonuclease inhibitor, a protein with leucine-rich repeats.

Authors:  F S Lee; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  A comparison of the predicted and X-ray structures of angiogenin. Implications for further studies of model building of homologous proteins.

Authors:  S C Allen; K R Acharya; K A Palmer; R Shapiro; B L Vallee; H A Scheraga
Journal:  J Protein Chem       Date:  1994-10

7.  Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity.

Authors:  J Moroianu; J F Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

8.  Angiogenin supports endothelial and fibroblast cell adhesion.

Authors:  F Soncin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  Neomycin inhibits angiogenin-induced angiogenesis.

Authors:  G F Hu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

Review 10.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.